US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NYSE
Embotelladora Andina (AKO.A)
Embotelladora Andina (AKO.A) ニュース

Embotelladora Andina (AKO.A)

23.96

0.00

(0.00%)

終了 7月11日 5:00AM

23.94

0.00

(0.00%)

取引時間後: 8:54AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

NYSE Content Update: HumanX to Ring Remote Bell with 350+ Speakers On Site

NYSE Content Update: HumanX to Ring Remote Bell with 350+ Speakers On Site PR Newswire NEW YORK, April 8...

NYSE Content Update: HumanX to Ring Remote Bell with 350+ Speakers On Site

NYSE Content Update: HumanX to Ring Remote Bell with 350+ Speakers On Site Canada NewsWire NEW YORK, April...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6...

Annual and Transition Report (foreign Private Issuer) (20-f)

126.27155.65122.75138.89171.21135.020000000000NYSE00000000000000925261--12-312022FYfalsefalsefalsefalse000000000...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Schedule 13g
(sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K ...

shajandr

shajandr 2分前

Dave:

Prison - you're nott gonna like big boy prison.

https://investorshub.advfn.com/uimage/uploads/2026/7/11/exmlgbeaumont.jpg
https://investorshub.advfn.com/uimage/uploads/2014/3/21/m[igcinmateArrival.jpg
https://investorshub.advfn.com/uimage/uploads/202

chereb19

chereb19 12分前

Every time you're wrong, you don't revisit your thesis—you just invent a new one. First it was "they'll never get an IDE." Then it became "it's only an EFS IDE." Now it's dilution, patents and OTC. The conclusion never changes; only the excuse does.

You're throwing everything at the w

Kool Aid Man

Kool Aid Man 15分前

Q:--"Why would a Royal Qatari Sheikh worth multi-millions need an infamous, maxed out, toxic ticker littered with legal landmines in order to 'self fund' mining and drilling on at least 3 continents then split his profits with decades of old HIRU bag holders???"

A: He doesn't

shajandr

shajandr 18分前

Roofie the prison janitor.

jjjjjjjj

jjjjjjjj 26分前

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3
IT IS DAMNED IF IT GOES UP, DAMNED IF IT GOES DOWN!
Which is it??? I repeat: IT IS DAMNED IF IT GOES UP. DAMNED IF IT GOES DOWN! Is today Mond

Kool Aid Man

Kool Aid Man 26分前

Has the bank said "no money was lost"? Then why are they suing?

rosemountbomber

rosemountbomber 46分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 48分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 58分前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 1時間前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 1時間前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 1時間前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 1時間前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 1時間前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Genz2 1時間前

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 1時間前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 2時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Embotelladora Andina

0.9% until 14feb2027

Jpmorgan Chase Financial...

DJ Internet Composite Ne...

Pebblebrook Hotel

OMX Copenhagen Financial...

Mercantile Investment

Pantera Minerals (QB)

Allspring Government Mon...

OMX Copenhagen GI

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。